Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 effects on gastric emptying during euglycaemia and hypoglycaemia
ACTRN12611000973910Phase 2Recruiting
- Sponsor
- Dr Mark Plummer
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Glucagon-like peptide 1 (4 arms), sponsored by Dr Mark Plummer. Primary endpoint: Gastric emptying. Started Aug 2011; status: recruiting.
02
Drugs
Glucagon-like peptide 1
Beyond the preview
Go deeper on ACTRN12611000973910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000973910.